Anew Medical, Stock EBITDA
WENAWDelisted Stock | 0.04 0.01 30.79% |
Anew Medical, fundamentals help investors to digest information that contributes to Anew Medical,'s financial success or failures. It also enables traders to predict the movement of Anew Stock. The fundamental analysis module provides a way to measure Anew Medical,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anew Medical, stock.
Anew |
Anew Medical, Company EBITDA Analysis
Anew Medical,'s EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Anew Medical, EBITDA | (574.23 K) |
Most of Anew Medical,'s fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Anew Medical, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Anew Medical, reported earnings before interest,tax, depreciation and amortization of (574,227). This is 100.1% lower than that of the Industrials sector and significantly lower than that of the Shell Companies industry. The ebitda for all United States stocks is 100.01% higher than that of the company.
Anew EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anew Medical,'s direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Anew Medical, could also be used in its relative valuation, which is a method of valuing Anew Medical, by comparing valuation metrics of similar companies.Anew Medical, is currently under evaluation in ebitda category among its peers.
Anew Fundamentals
EBITDA | (574.23 K) | |||
Net Income | (598.59 K) | |||
Total Debt | 1.35 M | |||
Cash Flow From Operations | (599.57 K) | |||
Total Asset | 2.54 M | |||
Retained Earnings | (3.22 M) | |||
Working Capital | (1.03 M) | |||
Net Asset | 2.54 M |
About Anew Medical, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anew Medical,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anew Medical, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anew Medical, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Anew Stock
If you are still planning to invest in Anew Medical, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anew Medical,'s history and understand the potential risks before investing.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamental Analysis View fundamental data based on most recent published financial statements |